Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity

Caroline Benedicte Kjærulff Mathiesen

Research output: Contribution to conference without a publisher/journalPosterCommunication

Original languageDanish
Publication date29 Aug 2018
Publication statusPublished - 29 Aug 2018
EventBenzon Symposia - 2018 - Hotel skt. Petri
Duration: 27 Aug 201830 Aug 2018


ConferenceBenzon Symposia - 2018
LocationHotel skt. Petri

Cite this